Literature DB >> 21864923

Helical tomotherapy for resected malignant pleural mesothelioma: dosimetric evaluation and toxicity.

Philippe Giraud1, Alma Sylvestre, Sofia Zefkili, Albert Lisbona, Pierre Bonnette, Françoise Le Pimpec Barthes, Edouard Paris, Christian Perigaud, Alexia Savignoni, Marc-André Mahé.   

Abstract

This study evaluated adjuvant helical tomotherapy after extrapleural pneumonectomy ± neo-adjuvant chemotherapy in 24 patients with malignant pleural mesothelioma. Toxicity was judged acceptable despite 2 cases (8%) of suspected grade 5 pneumonitis. With a mean follow-up of 7 months, 5 patients had distant and 2 local and distant failure.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2011        PMID： 21864923     DOI： 10.1016/j.radonc.2011.06.040

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  11 in total

1.  Extra-pleural pneumonectomy in the era of image-guided intensity-modulated radiotherapy.

Authors:  Marco Trovo; Davide Franceschini; Carlo Furlan; Francesca Pietrobon; Stefano Vagge; Eleonora Farina; Alberto Revelant; Luca Visani; Virginia Maragna; Giuseppe Parisi; Vieri Scotti
Journal:  Radiol Med       Date:  2019-04-08       Impact factor: 3.469

2.  Stereotactic body radiation therapy for a new lung cancer arising after pneumonectomy: dosimetric evaluation and pulmonary toxicity.

Authors:  Alessandro Testolin; Maria Silvia Favretto; Stefania Cora; Carlo Cavedon
Journal:  Br J Radiol       Date:  2015-08-20       Impact factor: 3.039

Review 3.  Malignant pleural mesothelioma: adjuvant therapy with radiation therapy.

Authors:  Kenneth E Rosenzweig
Journal:  Ann Transl Med       Date:  2017-06

4.  Malignant pleural mesothelioma - Pleural cavity irradiation after decortication with helical tomotherapy.

Authors:  Semi B Harrabi; Stefan A Koerber; Sebastian Adeberg; Sonja Katayama; Klaus Herfarth; Juergen Debus; Florian Sterzing
Journal:  Rep Pract Oncol Radiother       Date:  2017-08-11

Review 5.  Proton beam therapy for malignant pleural mesothelioma.

Authors:  Shahed N Badiyan; Jason K Molitoris; Mingyao Zhu; Erica Glass; Tejan Diwanji; Charles B Simone
Journal:  Transl Lung Cancer Res       Date:  2018-04

6.  Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma.

Authors:  Elizabeth H Baldini; William G Richards; Ritu R Gill; Brian M Goodman; Olivia K Winfrey; Hannah M Eisen; Raymond H Mak; Aileen B Chen; David E Kozono; Raphael Bueno; David J Sugarbaker
Journal:  J Thorac Cardiovasc Surg       Date:  2015-02-07       Impact factor: 5.209

Review 7.  The role of radical radiotherapy in the management of malignant pleural mesothelioma: A systematic review.

Authors:  Miranda Ashton; Noelle O'Rourke; Suzanne Currie; Andreas Rimner; Anthony Chalmers
Journal:  Radiother Oncol       Date:  2017-08-28       Impact factor: 6.280

8.  Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Hedy L Kindler; Nofisat Ismaila; Samuel G Armato; Raphael Bueno; Mary Hesdorffer; Thierry Jahan; Clyde Michael Jones; Markku Miettinen; Harvey Pass; Andreas Rimner; Valerie Rusch; Daniel Sterman; Anish Thomas; Raffit Hassan
Journal:  J Clin Oncol       Date:  2018-01-18       Impact factor: 44.544

9.  Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy.

Authors:  Tomoki Kimura; Yoshiko Doi; Takeo Nakashima; Nobuki Imano; Tsuyoshi Katsuta; Shigeo Takahashi; Masahiro Kenjo; Shuichi Ozawa; Yuji Murakami; Yasushi Nagata
Journal:  J Radiat Res       Date:  2015-01-18       Impact factor: 2.724

10.  Functional image guided radiation therapy planning in volumetric modulated arc therapy for patients with malignant pleural mesothelioma.

Authors:  Yoshiko Doi; Tomoki Kimura; Takeo Nakashima; Yuki Takeuchi; Ippei Takahashi; Ikuno Nishibuchi; Yuji Murakami; Yasushi Nagata
Journal:  Adv Radiat Oncol       Date:  2017-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.